QUAKER CHEMICAL CORPORATION Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net
QUAKER CHEMICAL CORPORATION (KWR) reported Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net of $163.00 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Income Statement › Other Income
us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet · last filed 2022-11-03
- QUAKER CHEMICAL CORPORATION derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2022-09-30 was $466.00K.
- QUAKER CHEMICAL CORPORATION derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2021-12-31 was -$776.00K.
- QUAKER CHEMICAL CORPORATION derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2021-09-30 was -$436.00K.
- QUAKER CHEMICAL CORPORATION derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2020-12-31 was -$460.00K.
- QUAKER CHEMICAL CORPORATION derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2014 was $0.00.
- QUAKER CHEMICAL CORPORATION derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2013 was $0.00.
- QUAKER CHEMICAL CORPORATION derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2012 was $0.00.
- QUAKER CHEMICAL CORPORATION derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2011 was $0.00.
| Period end | Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 3 month | Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 6 month | Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 9 month | Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 12 month |
|---|---|---|---|---|
| 2022-09-30 | $466.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $163.00K 10-Q · filed 2022-11-03 | ||
| 2022-06-30 | -$303.00K 10-Q · filed 2022-08-04 | |||
| 2021-12-31 | -$776.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2022-11-03 | -$1.21M derived: sum of 2 quarters · filed 2022-11-03 | $1.37M 10-Q · filed 2022-11-03 | |
| 2021-09-30 | -$436.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $2.15M 10-Q · filed 2021-11-04 | ||
| 2021-06-30 | $2.58M 10-Q · filed 2021-08-05 | |||
| 2020-12-31 | -$460.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2021-11-04 | -$814.00K derived: sum of 2 quarters · filed 2021-11-04 | $3.60M 10-Q · filed 2021-11-04 | |
| 2020-09-30 | -$354.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $4.06M 10-Q · filed 2020-11-05 | ||
| 2020-06-30 | $4.41M 10-Q · filed 2020-08-05 | |||
| 2019-12-31 | $320.00K 10-Q · filed 2020-11-05 | |||
| 2014-12-31 | $0.00 10-K · filed 2015-02-26 | |||
| 2013-12-31 | $0.00 10-K · filed 2015-02-26 | |||
| 2012-12-31 | $0.00 10-K · filed 2015-02-26 | |||
| 2011-12-31 | $0.00 10-K · filed 2014-02-28 | |||
| 2010-12-31 | $0.00 10-K · filed 2013-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VALVOLINE INC (VVV) | United States | $3.618B | 49.71 |